HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design A Review
This book gathers a series of pivotal papers on the development of an HIV/AIDS vaccine published in the last two decades. Accompanied by extensive comments putting the material into an up-to-date context, all three parts of the book offer a broad overview
- PDF / 5,538,738 Bytes
- 379 Pages / 439.42 x 683.15 pts Page_size
- 92 Downloads / 194 Views
HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design A Review of 20 Years of Research
HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design
Marc H V Van Regenmortel
HIV/AIDS: Immunochemistry, Reductionism and Vaccine Design A Review of 20 Years of Research
Marc H V Van Regenmortel School of Biotechnology University of Strasbourg Illkirch, France
ISBN 978-3-030-32458-2 ISBN 978-3-030-32459-9 https://doi.org/10.1007/978-3-030-32459-9
(eBook)
© Springer Nature Switzerland AG 2019 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG. The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Introduction
According to UNAIDS, during the year 2016, 36.7 million people on our planet were living with HIV, while 1.8 million people were newly infected by the virus. Since the start of the epidemic in the mid-80s, 35 million people have died of AIDS-related illnesses. Although considerable progress has been made in the treatment of HIV patients with antiretroviral drugs, it is now increasingly accepted that only an effective HIV vaccine will be able to end the AIDS pandemic. A few large-scale HIV vaccine trials have been undertaken, but none, so far, has elicited an adequate level of protection against infection. It may seem paradoxical that although HIV has become the virus we know most about, after three decades of unparalleled high-quality research funded by billions of dollars, we are not yet sure whether a preventive HIV vaccine will ever be developed. This eBook brings together 24 scientific papers published by the author in the last 20 years which propose explanations for why it has been so difficult to develop a vaccine against what is probably the worst pandemic that has confronted humanity in recent times. The book is divided into three par
Data Loading...
